REGISTER now for FREE 
|
FREE patent keyword monitoring and additional FREE benefits. REGISTER now for FREE
|
|
|
Drug, Bio-affecting And Body Treating Compositions > Inorganic Active Ingredient Containing > Heavy Metal Or Compound Thereof Heavy Metal Or Compound ThereofHeavy Metal Or Compound Thereof patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.07/05/07 - 20070154566 - Method for preparing therapeutic agent for cancer A method for the production of a material for cancer treatment, which comprises preparing a first aqueous acidic to neutral solution containing a metal to be insoluble in an alkaline solution and a carboxylic acid amide, and a second aqueous solution containing an enzyme catalyzing hydrolysis of the carboxylic acid ... 06/07/07 - 20070128294 - Treatment and prevention of liver adverse conditions using gallium The invention provides methods and compositions for treating adverse conditions of the liver in an individual. A pharmaceutical composition including gallium, in the form of a coordination complex of gallium (III), a salt of gallium (III), an inorganic gallium (III) compound other than a gallium salt, or protein-bound gallium (III), ... 05/24/07 - 20070116782 - Use of rare earth compounds for the prevention of kidney stone disease Conditions such as kidney stones, which are characterized by undesired absorption of oxalate from the intestinal tract are conveniently treated using nontoxic salts of rare earth metal ions. ... 05/10/07 - 20070104799 - Treatment of chronic kidney disease (ckd) subjects using lanthanum compounds A subject with symptoms of chronic kidney disease (CKD), who does not have end-stage renal disease (ESRD), can be treated by orally administering a pharmaceutical composition as an active ingredient a therapeutically effective amount of a non-toxic lanthanum compound. Administration of a lanthanum compound can prevent the progression of CKD, ... 05/03/07 - 20070098815 - Orally administrable gallium compositions and methods of use Provided are pharmaceutical gallium compositions that are particularly useful for oral administration. The pharmaceutical compositions include solid, liquid, and paste formulations, which have high oral gallium bioavailability and are suitable for human and veterinary applications. The compositions comprise pharmaceutically acceptable gallium compounds, such as gallium maltolate, gallium 8-quinolinolonate, or gallium ... 05/03/07 - 20070098814 - Medical device's manufacture and usage in alternative medicine for rehabilitation treatment of chronic diseases This invention provides information regarding the methods and procedures for manufacturing a new medical device, Health recovery chip kit. It also describes the methods and steps for using this kit to treat the chronic, but non-contagious diseases. The treatment by this kit is safe, more effective, non-invasive and easy to ... 03/08/07 - 20070053994 - Anti-inflammatory treatment The invention provides a method of treatment of a human or non-human animal subject to combat inflammation arising from a condition associated with pain or a condition not associated with pain, said method comprising administering to said subject an effective amount of a physiologically tolerable strontium compound. ... 03/01/07 - 20070048390 - Combination of a lanthanum compound and bone enhancing agent for the treatment of bone diseases The invention provides a method for enhancing bone formation, inhibiting osteoclastic differentiation and/or activating osteoblastic differentiation whereby to manage, treat or achieve prophylaxis of bone disease which comprises administering to a human or animal subject suffering from, or susceptible to bone disease a therapeutically or prophylactically effective amount of a ... 12/07/06 - 20060275503 - Combination treatment with strontium for the prophylaxis and/or treatment of cartilage and/or bone conditions A combination treatment, wherein a strontium-containing compound together with one or more active substances capable of reducing the incidence of bone fracture and/or increasing bone density and/or improving healing of fractured bone and/or improving bone quality are administered for use in the treatment and/or prophylaxis of cartilage and/or bone conditions. ... 11/16/06 - 20060257500 - Trpc6 involved in glomerulonephritis Focal and segmental glomerulosclerosis (FSGS) is a kidney disorder of unknown etiology and up to 20% of patients on dialysis have this diagnosis. A large family with hereditary FSGS carries a missense mutation in the TRPC6 gene on chromosome 11q, encoding the ion channel protein Transient Receptor Potential Cation Channel ... 11/09/06 - 20060251730 - Anti-microbial sanitary ware and method for making the same An anti-microbial sanitary ware includes a substrate, and an anti-microbial film formed on the substrate and including a protective layer and anti-microbial metal particles that are dispersed in the protective layer. The protective layer is made from a compound selected from the group consisting of metal nitrides and metal carbides. ... 11/02/06 - 20060246152 - Inhibition of reactive oxygen species and protection of mammalian cells Methods and compositions useful for neuronal protection in retinal cells in vitro and the protection of mammalian cells from reactive oxygen species in vivo are provided. Ultrafine nano-size cerium oxide particles, less than 10 nanometers in diameter, have been provided to decrease reactive oxygen species (ROS) in retina tissue that ... 11/02/06 - 20060246151 - Agricultural, horticultural and veterinary compositions A composition suitable for veterinary, agricultural or horticultural use is disclosed which comprises at least one organic veterinarally, agriculturally and/or horticulturally active compound, and titanium dioxide and/or zinc oxide which has been doped with a second element and/or reduced zinc oxide as well as a composition suitable for household use ... 10/12/06 - 20060228424 - Phosphorus binder for treatment of kidney disease The present invention relates to oral compositions which are useful for binding phosphorus in ingesta, and inhibiting absorption of phosphorus from the gastrointestinal tract of subjects. A method for binding phosphorus in ingesta and inhibiting its absorption from the gastrointestinal tract is also provided. The dietary supplements and pharmaceutical products ... 09/21/06 - 20060210646 - Accelerator for mineral absorption and use thereof The present invention has an object to provide an accelerator for mineral absorption and a composition containing the accelerator. The object is solved by providing an accelerator for mineral absorption comprising cyclic tetrasaccharide and/or saccharide derivatives thereof and a composition containing the accelerator. ... 07/13/06 - 20060153932 - Method of treating hyperphosphataemia using lanthanum hydroxycarbonate This disclosure relates to the treatment of subjects at risk for chronic kidney disease (CKD), having stage one to five CKD, having hyperphosphataemia, susceptible to or suffering from soft tissue calcification associated with CKD, or susceptible to or suffering from hyperparathyroidism, by orally administering a pharmaceutical composition containing a therapeutically ... 07/13/06 - 20060153931 - Prevention of flap necrosis in plastic surgery NO, NO donor or prodrug that causes formation of nitrosothiol in tissue optionally in combination with lidocaine is topically applied to pedicle of a pedicle flap or other source of blood supply to prevent necrosis in pedicle flap or in any microvascular surgery. Composition containing drug is formulated with nitrosylated ... 07/06/06 - 20060147548 - Therapeutic delivery of carbon monoxide Metal carbonyls are used in combination with at least one guanylate cyclase stimulant/stabilizer to deliver CO having biological activity, for example vasodilatation and inhibition of platelet aggregation. The two components may be administered simultaneously or sequentially. A particular described combination is tricarbonylchloro(glycinato)ruthenium(II) and the drug YC-1. ... 06/22/06 - 20060134225 - Phosphate binder with reduced pill burden The present invention is generally directed to compositions and formulations that can be used for the treatment of diseases such as End Stage Renal Disease (“ESRD”) and Chronic Renal Insufficiency (“CRI”). Specifically, it is directed to lanthanum-based compounds that bind phosphate and that can be formulated to provide for a ... 06/08/06 - 20060121127 - Stabilized lanthanum carbonate compositions Stabilized lanthanum carbonate compositions containing a monosaccharide or disaccharide stabilizing agent are disclosed. Subjects having hyperphosphatemia can be treated by administering a pharmaceutical composition containing a therapeutically effective amount of the stabilized lanthanum carbonate formulation. ... 04/20/06 - 20060083791 - Rare earth metal compounds methods of making, and methods of using the same Rare earth metal compounds, particularly lanthanum, cerium, and yttrium, are formed as porous particles and are effective in binding metals, metal ions, and phosphate. A method of making the particles and a method of using the particles is disclosed. The particles may be used in the gastrointestinal tract or the ... 02/16/06 - 20060034942 - Molluscicide delivery system A delivery system for controlling attack by molluscs, comprising a plant fibre substrate onto which has been loaded a metallic salt, such as by spraying with or immersing the substrate in an aqueous solution of the salt, the metallic ion of that salt being one which is toxic to molluscs, ... 01/12/06 - 20060008534 - Crystal liquid/crystal bioenergy device My invention capitalizes on the fact that a crystal in resonance with a liquid such as water in a tube or closed container, acts to either pattern the liquid to a desired set of frequencies, or to act as an electromagnetic attractant to assimilate and clear adverse energies from the ... 01/05/06 - 20060003018 - Rare earth metal compositions for treating hyperphosphatemia and related methods Rare earth metal compounds, particularly lanthanum, cerium, and yttrium, are formed as porous particles and are effective in binding metals, metal ions, and phosphate. A method of making the particles and a method of using the particles is disclosed. The particles may be used in the gastrointestinal tract or the ... 12/29/05 - 20050287225 - Metal cluster nano-compounds for treating tumor diseases The invention relates to metal cluster nano-compounds of transition metals, which includes a metal nucleus formed from atoms of at least one transition metal and at least one ligand, and including their physiologically compatible salts, derivatives, isomers, hydrates, metabolites and prodrugs, which are suited for the prophylactic and/or therapeutic (curative) ... 11/10/05 - 20050249817 - Magnetic particle composition for therapeutic hyperthermia Magnetic nanoparticle compositions are provided which provide an inherent temperature regulator for use in magnetic heating, particularly for use in magnetic hyperthermia medical treatments. The composition includes magnetic nanoparticles having a Curie temperature of between 40 and 46° C., preferably about 42° C., and may further include a polymeric material ... 11/03/05 - 20050244510 - Compositions for improving mental performance The present invention provides formulas for producing compositions for the structural/functional nutritional support for those who struggle with poor focus, concentration and/or memory. In addition, the present invention provides compositions comprising nutritional/botanical factors helpful to those who subjectively experience transient mental fatigue or poor cognitive function. The compositions of this ... 10/27/05 - 20050238729 - Inhibition of biogenic sulfide production via biocide and metabolic inhibitor combination Biogenic sulfide production is synergistically inhibited by treating sulfate-reducing bacteria (SRB) with a biocide and a metabolic inhibitor. The biocide directly kills a first portion of the SRB. The metabolic inhibitor inhibits sulfate-reducing growth of a second portion of the SRB without directly killing the second portion of the SRB. ... 10/06/05 - 20050220895 - Use of gallium to treat inflammatory arthritis Methods are provided for the use of gallium in the treatment or prevention of inflammatory arthritis conditions such as rheumatoid arthritis. ... 09/15/05 - 20050202099 - Anti-microbial sanitary ware and method for making the same An anti-microbial sanitary ware includes a substrate, and an anti-microbial film formed on the substrate and including a protective layer and anti-microbial metal particles that are dispersed in the protective layer. The protective layer is made from a compound selected from the group consisting of metal nitrides and metal carbides. ... 08/25/05 - 20050186288 - Compositions and methods for the prophylaxis and treatment of aphthous ulcers and herpes simplex lesions Disclosed is a topical method for providing highly effective analgesic, anti-inflammatory, antimicrobial and tissue-regenerating activities for the hitherto most effective prophylaxis and treatment of aphthous ulcers and herpes simplex lesions and for the effective treatment of burns and other oral mucosal lesions as well as for prophylaxis and treatment of ... 08/25/05 - 20050186287 - Copper agonist that binds on the copper binding site of app and/or exerts an inhibiting effect on the release of amyloid abeta peptide The invention relates to copper agonists that bind on the copper binding site of APP and/or exert an inhibiting effect on the release of the amyloid Aβ peptide participating in the emergence of Alzheimer's disease. The invention also relates to the drugs containing said copper agonists or to the utilization ... 06/02/05 - 20050118280 - Micronized wood preservative formulations The present invention provides wood preservative compositions comprising micronized particles. In one embodiment, the composition comprises dispersions of micronized metal or metal compounds. In another embodiment, the wood preservative composition comprises an inorganic component comprising a metal or metal compound and organic biocide. When the composition comprises an inorganic component ... 06/02/05 - 20050118279 - Mineral, nutritional, cosmetic, pharmaceutical, and agricultural compositions and methods for producing the same Mineral, cosmetic, pharmaceutical, agricultural, nutraceutical, and other compositions are produced using a mineral composition containing minimal concentrations of cadmium, lead, arsenic, and mercury and containing relatively high concentrations of micro and macro mineral elements, of rare earth elements, of calcium, and of silica. The mineral concentrations are produced by processing ... 06/02/05 - 20050118278 - Pharmaceutical or cosmetic composition, preventing or reducing itch and local reaction from stings of insects The present invention relates to medicine, more particularly to pharmaceutical or cosmetic compositions, used for application on the skin, including the region of eyes, as well as on the lips and the mucosa of nasal, oral and laryngeal cavities of the man or the animal, with the purpose of preventing ... ### FreshPatents.com Support |